{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:38:45Z","timestamp":1786991925348,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"OP Prague Competitiveness","award":["CZ.2.16\/3.1.00\/21565"],"award-info":[{"award-number":["CZ.2.16\/3.1.00\/21565"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jccjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jcrc.2017.04.027","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T00:47:29Z","timestamp":1493167649000},"page":"16-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Propafenone for supraventricular arrhythmias in septic shock\u2014Comparison to amiodarone and metoprolol"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1864-2143","authenticated-orcid":false,"given":"M.","family":"Balik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Kolnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Maly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Waldauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Tavazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kristof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jcrc.2017.04.027_bb0005","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00134-007-0929-z","article-title":"Cardiac morphological and functional changes during early septic shock: a transesophageal echocardiographic study","volume":"34","author":"Etchecopar-Chevreuil","year":"2008","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1016\/j.jcrc.2017.04.027_bb0010","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s001340050372","article-title":"Left ventricular systolic and diastolic function in septic shock","volume":"23","author":"Poelaert","year":"1997","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.jcrc.2017.04.027_bb0015","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1097\/01.CCM.0000266683.64081.02","article-title":"Mechanisms of sepsis-induced cardiac dysfunction","volume":"35","author":"Rudiger","year":"2007","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.jcrc.2017.04.027_bb0020","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/CCM.0B013E31816596BC","article-title":"Isolated and reversible impairment of ventricular relaxation in patients with septic shock","volume":"36","author":"Bouhemad","year":"2008","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.jcrc.2017.04.027_bb0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1164\/rccm.201603-0618OC","article-title":"Incidence, predictors and outcomes of new-onset atrial fibrillation in critically ill patients with sepsis: a cohort study","volume":"195","author":"Klein Klouwenberg","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.jcrc.2017.04.027_bb0030","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1164\/ajrccm.160.2.9810073","article-title":"Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach","volume":"160","author":"Annane","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.jcrc.2017.04.027_bb0035","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/shk.0b013e31812386bf","article-title":"Endotoxin impairs the human pacemaker current If","volume":"28","author":"Zorn-Pauly","year":"2007","journal-title":"Shock"},{"issue":"5","key":"10.1016\/j.jcrc.2017.04.027_bb0040","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00075198-200110000-00002","article-title":"Autonomic dysfunction in the ICU patient","volume":"7","author":"Schmidt","year":"2001","journal-title":"Curr Opin Crit Care"},{"issue":"6","key":"10.1016\/j.jcrc.2017.04.027_bb0045","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1186\/s13054-014-0688-5","article-title":"Incidence, risk factors and outcomes of new-onset atrial fibrillation in patients with sepsis: a systematic review","volume":"18","author":"Kuipers","year":"2014","journal-title":"Crit Care"},{"issue":"840615","key":"10.1016\/j.jcrc.2017.04.027_bb0050","article-title":"Management of atrial fibrillation in critically ill patients","volume":"2014","author":"Arrigo","year":"2014","journal-title":"Crit Care Res Pract"},{"issue":"6","key":"10.1016\/j.jcrc.2017.04.027_bb0055","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/cc6136","article-title":"Clinical review: treatment of new-onset atrial fibrillation in medical intensive care patients\u2014a clinical framework","volume":"11","author":"Sleeswijk","year":"2007","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.jcrc.2017.04.027_bb0060","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/europace\/eut263","article-title":"Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events\u2014European Registry in Atrial Fibrillation (PREFER in AF)","volume":"16","author":"Kirchhof","year":"2014","journal-title":"Europace"},{"issue":"11","key":"10.1016\/j.jcrc.2017.04.027_bb0065","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1097\/CCM.0000000000001257","article-title":"Disappointing success of electrical cardioversion for new-onset atrial fibrillation in cardiosurgical ICU patients","volume":"43","author":"Arrigo","year":"2015","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2017.04.027_bb0070","series-title":"Intensive care medicine","first-page":"1486","article-title":"Antiarythmic agents","author":"Ganetsky","year":"2008"},{"issue":"12","key":"10.1016\/j.jcrc.2017.04.027_bb0075","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial","volume":"324","author":"Echt","year":"1991","journal-title":"NEJM"},{"issue":"2","key":"10.1016\/j.jcrc.2017.04.027_bb0080","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0735-1097(02)02705-5","article-title":"Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis","volume":"41","author":"Chevalier","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jcrc.2017.04.027_bb0085","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5603\/CJ.2013.0035","article-title":"Arrhythmogenic effect of flecainide toxicity","volume":"20","author":"Courand","year":"2013","journal-title":"Cardiol J"},{"issue":"2","key":"10.1016\/j.jcrc.2017.04.027_bb0090","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/europace\/euq382","article-title":"Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation","volume":"13","author":"Aliot","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.jcrc.2017.04.027_bb0095","series-title":"Irwin and Rippe's intensive care medicine","first-page":"1855","article-title":"The Management of Sepsis","author":"Varon","year":"2008"},{"issue":"2","key":"10.1016\/j.jcrc.2017.04.027_bb0100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00134-011-2448-1","article-title":"On the role of left ventricular diastolic function in the critically ill patient","volume":"38","author":"Saleh","year":"2012","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1016\/j.jcrc.2017.04.027_bb0105","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1097\/CCM.0b013e31828a678d","article-title":"Microvascular effects of heart rate control with esmolol in patients with septic shock: a pilot study","volume":"41","author":"Morelli","year":"2013","journal-title":"Crit Care Med"},{"issue":"16","key":"10.1016\/j.jcrc.2017.04.027_bb0110","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jama.2013.278477","article-title":"Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial","volume":"310","author":"Morelli","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2017.04.027_bb0115","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00508-012-0209-y","article-title":"Concomitant use of beta-1 adrenoreceptor blocker and norepinephrine in patients with septic shock","volume":"124","author":"Balik","year":"2012","journal-title":"Wien Klin Wochenschr"},{"issue":"7\u20138","key":"10.1016\/j.jcrc.2017.04.027_bb0120","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00508-013-0487-z","article-title":"Concomitant use of beta-1 adrenoreceptor blocker and norepinephrine in patients with septic shock. Reply to a letter to the authors","volume":"126","author":"Balik","year":"2014","journal-title":"Wien Klin Wochenschr"},{"issue":"10","key":"10.1016\/j.jcrc.2017.04.027_bb0125","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1007\/s00134-016-4407-3","article-title":"Beta-blockers in septic shock to optimize hemodynamics? No","volume":"42","author":"McLean","year":"2016","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.jcrc.2017.04.027_bb0130","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS international sepsis definitions conference","volume":"31","author":"Levy","year":"2003","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1016\/j.jcrc.2017.04.027_bb0135","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1164\/rccm.201502-0329OC","article-title":"Acute kidney injury requiring dialysis in severe sepsis","volume":"192","author":"Sakhuja","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.jcrc.2017.04.027_bb0140","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jcrc.2017.04.027_bb0145","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/00003643-200409000-00006","article-title":"Transthoracic echocardiography for cardiopulmonary monitoring in intensive care","volume":"21","author":"Jensen","year":"2004","journal-title":"Eur J Anaesthesiol"},{"issue":"15\u201316","key":"10.1016\/j.jcrc.2017.04.027_bb0150","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00508-008-1017-2","article-title":"Incidence and predictability of amiodarone-induced thyrotoxicosis and hypothyroidism","volume":"120","author":"Hofmann","year":"2008","journal-title":"Wien Klin Wochenschr"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944117301363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944117301363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T18:25:48Z","timestamp":1658946348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944117301363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":30,"alternative-id":["S0883944117301363"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2017.04.027","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Propafenone for supraventricular arrhythmias in septic shock\u2014Comparison to amiodarone and metoprolol","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2017.04.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}